Results 111 to 120 of about 68,877 (195)

Transient non-local interactions dominate the dynamics of measles virus N_TAIL. [PDF]

Commun Chem
Otteson L, Nagy G, Kunkel J, Kodis G, Bock LV, Bignon C, Longhi S, Zheng W, Grubmüller H, Vaiana AC, Vaiana SM.   +10 more
europepmc   +1 more source

Repurposing the SSRI paroxetine increases lymphocyte mobilization and improves the efficacy of measles virus-based immunovirotherapy. [PDF]

Mol Ther Oncol
Stergiopoulos GM, Concilio SC, Viker KB, Clark SM, Robinson SI, Galanis E.   +5 more
europepmc   +1 more source

A Case of Measles Virus-caused Subacute Sclerosing Panencephalitis Diagnosed by Molecular and Clinical Analysis. [PDF]

Open Forum Infect Dis
Liu T, Zhang C, Ming M, Chen L, Chen W, Xu Y, Shen M, Liu J, Ou Q, Bao H, Chen X, Lu G, Yan G.   +12 more
europepmc   +1 more source

Genetic characterization of measles virus circulating in Iran, 2021-2023. [PDF]

BMC Infect Dis
Amiryli AE, Abbasi S, Tarpoor F, Shadab A, Saboori A, Jandaghi NS, Salimi V, Mokhtari-Azad T.   +7 more
europepmc   +1 more source

Epidemiology, clinical overview, and potential risk of a new pandemic of measles virus. [PDF]

Infect Dis Immun
Bassetti M, Giacobbe DR, Sepulcri C, Labate L.   +3 more
europepmc   +1 more source

Correction to: Erratum to: TRLS-11. PNOC005: ONCOLYTIC MEASLES VIRUS FOR THE TREATMENT OF CHILDREN AND YOUNG ADULTS WITH RECURRENT MEDULLOBLASTOMA OR ATYPICAL TERATOID RHABDOID TUMOR. [PDF]

Neuro Oncol
europepmc   +1 more source

A Short Peptide Inhibitor of Measles Virus Fusion Protein that Exhibits Passive Membrane Permeability. [PDF]

ChemMedChem
Gao Z, Sasaki J, Suzuki T, Sando S, Hashiguchi T, Morimoto J.   +5 more
europepmc   +1 more source

Measles Virus [PDF]

, 2020
openaire   +1 more source

Measles Virus-Based Genetic Modifications: Progress in Hematological Malignancy Treatment. [PDF]

Onco Targets Ther
Lan S, Zhao Z, He Z.
europepmc   +1 more source